Research tools
Analyst Ratings Screener
Find recent upgrades, downgrades, initiations, and reiterations by firm, rating, consensus, target upside, sector, and company size.
Save your best screens
Sign in to keep filters and sorting ready for your next visit.
3,844 matching rating changes
Export CSV| Date, sort lowest first | Symbol | Company | Firm | Action | Prior rating | New rating | Consensus | Analysts, sort highest first | Avg. target | Target upside, sort highest first | Market cap, sort highest first |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | XNCR | Xencor, Inc. | Raymond James | Main | Strong Buy | Strong Buy | — | — | $27.60 | +13.07% | 1.22B |
| Aug 31, 2026 | ABNB | Airbnb, Inc. | DA Davidson | Main | Buy | Buy | Buy | 30 | $138.00 | -18.91% | 81B |
| Aug 31, 2026 | ADBE | Adobe Inc. | Jefferies | Main | Hold | Hold | Hold | 27 | $413.33 | +63.87% | 109.84B |
| Aug 31, 2026 | ADSK | Autodesk, Inc. | Citigroup | Main | Neutral | Neutral | Buy | 25 | $373.40 | +75.80% | 52.37B |
| Aug 31, 2026 | ADSK | Autodesk, Inc. | Rosenblatt | Main | Buy | Buy | Buy | 25 | $373.40 | +75.80% | 52.37B |
| Aug 31, 2026 | AFRM | Affirm Holdings, Inc. | Bernstein | Main | Outperform | Outperform | — | — | $94.13 | +31.76% | 15.65B |
| Aug 31, 2026 | AFRM | Affirm Holdings, Inc. | Goldman Sachs | Main | Buy | Buy | — | — | $94.13 | +31.76% | 15.65B |
| Aug 31, 2026 | AFRM | Affirm Holdings, Inc. | Cantor Fitzgerald | Main | Overweight | Overweight | — | — | $94.13 | +31.76% | 15.65B |
| Aug 31, 2026 | AGCO | AGCO Corporation | Baird | Upgrade | Neutral | Outperform | Hold | 21 | $117.67 | -2.83% | 10.19B |
| Aug 31, 2026 | AHR | American Healthcare REIT, Inc. | Barclays | Main | Overweight | Overweight | — | — | $49.14 | -8.29% | 9.69B |
| Aug 31, 2026 | AIRJ | AirJoule Technologies Corporation | Needham | Initiated | — | Hold | Buy | 8 | $10.58 | +147.25% | 215.87M |
| Aug 31, 2026 | AMBA | Ambarella, Inc. | Rosenblatt | Main | Buy | Buy | — | — | $97.50 | +43.68% | 2.6B |
| Aug 31, 2026 | ANDG | Andersen | Baird | Main | Outperform | Outperform | — | — | — | — | 2.57B |
| Aug 31, 2026 | ARWR | Arrowhead Pharmaceuticals, Inc. | Chardan Capital | Main | Buy | Buy | — | — | $71.00 | -14.30% | 8.86B |
| Aug 31, 2026 | ARWR | Arrowhead Pharmaceuticals, Inc. | RBC Capital | Reiterated | Outperform | Outperform | — | — | $71.00 | -14.30% | 8.86B |
| Aug 31, 2026 | ASND | Ascendis Pharma A/S | HC Wainwright & Co. | Main | Buy | Buy | — | — | $246.67 | -6.39% | 14.33B |
| Aug 31, 2026 | ASND | Ascendis Pharma A/S | Jefferies | Main | Buy | Buy | — | — | $246.67 | -6.39% | 14.33B |
| Aug 31, 2026 | ASND | Ascendis Pharma A/S | Stifel | Main | Buy | Buy | — | — | $246.67 | -6.39% | 14.33B |
| Aug 31, 2026 | ASND | Ascendis Pharma A/S | B of A Securities | Main | Buy | Buy | — | — | $246.67 | -6.39% | 14.33B |
| Aug 31, 2026 | ATTO | Atento S.A. | LifeSci Capital | Initiated | — | Outperform | — | — | — | — | 6.84M |
| Aug 31, 2026 | ATTO | Atento S.A. | Citigroup | Initiated | — | Buy | — | — | — | — | 6.84M |
| Aug 31, 2026 | ATTO | Atento S.A. | Morgan Stanley | Initiated | — | Overweight | — | — | — | — | 6.84M |
| Aug 31, 2026 | ATTO | Atento S.A. | Leerink Partners | Initiated | — | Outperform | — | — | — | — | 6.84M |
| Aug 31, 2026 | ATTO | Atento S.A. | RBC Capital | Initiated | — | Outperform | — | — | — | — | 6.84M |
| Aug 31, 2026 | AXSM | Axsome Therapeutics, Inc. | HC Wainwright & Co. | Reiterated | Buy | Buy | — | — | $184.00 | -16.65% | 7.5B |
| Aug 31, 2026 | AZO | AutoZone, Inc. | TD Cowen | Main | Buy | Buy | Buy | 20 | $4,417.33 | +53.55% | 58.05B |
| Aug 31, 2026 | BDX | Becton, Dickinson and Company | B of A Securities | Main | Neutral | Neutral | Buy | 15 | $210.00 | +18.08% | 57.44B |
| Aug 31, 2026 | BMRN | BioMarin Pharmaceutical Inc. | Jefferies | Main | Buy | Buy | — | — | $80.58 | +22.69% | 10.18B |
| Aug 31, 2026 | BMRN | BioMarin Pharmaceutical Inc. | HC Wainwright & Co. | Main | Neutral | Neutral | — | — | $80.58 | +22.69% | 10.18B |
| Aug 31, 2026 | BNTX | BioNTech SE | Canaccord Genuity | Main | Buy | Buy | — | — | $144.75 | +49.64% | 23.08B |
| Aug 31, 2026 | BPOP | Popular, Inc. | Benchmark | Main | Buy | Buy | — | — | $153.00 | -6.54% | 8.06B |
| Aug 31, 2026 | BPOPO | Popular, Inc. | Benchmark | Main | Buy | Buy | — | — | — | — | 8.02B |
| Aug 31, 2026 | BR | Broadridge Financial Solutions, Inc. | RBC Capital | Main | Outperform | Outperform | Buy | 18 | $240.00 | +43.08% | 27.11B |
| Aug 31, 2026 | BRCC | BRC Inc. | DA Davidson | Main | Buy | Buy | — | — | $7.00 | -18.22% | 391.42M |
| Aug 31, 2026 | BURL | Burlington Stores, Inc. | Goldman Sachs | Main | Buy | Buy | — | — | $336.89 | +40.93% | 16.95B |
| Aug 31, 2026 | BURL | Burlington Stores, Inc. | Deutsche Bank | Main | Hold | Hold | — | — | $336.89 | +40.93% | 16.95B |
| Aug 31, 2026 | BW | Babcock & Wilcox Enterprises, Inc. | Needham | Initiated | — | Buy | — | — | $8.00 | +0.76% | 612.89M |
| Aug 31, 2026 | BWNB | Babcock & Wilcox Enterprises, I | Needham | Initiated | — | Buy | Buy | 11 | $30.98 | +23.12% | 89.54M |
| Aug 31, 2026 | BWSN | Babcock & Wilcox Enterprises, I | Needham | Initiated | — | Buy | — | — | — | — | 2.8B |
| Aug 31, 2026 | CIEN | Ciena Corporation | B. Riley Securities | Main | Neutral | Neutral | — | — | $197.50 | -43.50% | 34.24B |
| Aug 31, 2026 | CMP | Compass Minerals International, Inc. | Deutsche Bank | Main | Buy | Buy | — | — | $23.50 | -5.24% | 737.47M |
| Aug 31, 2026 | CPAY | Corpay, Inc. | RBC Capital | Main | Sector Perform | Sector Perform | — | — | $357.00 | -12.55% | 22.23B |
| Aug 31, 2026 | CPB | Campbell Soup Company | RBC Capital | Reiterated | Sector Perform | Sector Perform | — | — | $30.88 | +47.05% | 8.48B |
| Aug 31, 2026 | CPB | Campbell Soup Company | Evercore ISI Group | Main | In-Line | In-Line | — | — | $30.88 | +47.05% | 8.48B |
| Aug 31, 2026 | CRM | Salesforce, Inc. | Argus Research | Main | Buy | Buy | Buy | 36 | $324.17 | +30.86% | 250.77B |
| Aug 31, 2026 | CRSP | CRISPR Therapeutics AG | Citizens | Reiterated | Market Outperform | Market Outperform | — | — | $66.33 | +28.25% | 5.08B |
| Aug 31, 2026 | CRSP | CRISPR Therapeutics AG | Needham | Reiterated | Buy | Buy | — | — | $66.33 | +28.25% | 5.08B |
| Aug 31, 2026 | CSIQ | Canadian Solar Inc. | Wells Fargo | Main | Equal-Weight | Equal-Weight | Hold | 17 | $25.41 | +99.14% | 1.69B |
| Aug 31, 2026 | CYTK | Cytokinetics, Incorporated | HC Wainwright & Co. | Reiterated | Buy | Buy | — | — | $79.75 | +8.11% | 7.23B |
| Aug 31, 2026 | DE | Deere & Company | Baird | Upgrade | Neutral | Outperform | Buy | 15 | $529.50 | -21.64% | 128.64B |
